MedTrace Logo

Preoperative IV Versus Oral Acetaminophen

NCT03468920 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2019-05-14

Study results available
· View outcomes & findings →

Summary

The current study proposes to examine whether there is a significant difference in patient outcomes related to the administration route of preoperative Acetaminophen. Specifically, the study will compare outcomes of surgical patients who receive IV Acetaminophen with surgical patients who receive oral Acetaminophen.

Conditions

  • Pain, Postoperative

Interventions

DRUG

IV Acetaminophen

IV Acetaminophen 1000mg in 100mL normal saline once pre-operatively

DRUG

PO Acetaminophen

Acetaminophen PO 1000mg once pre-operatively

DRUG

PO Placebo

PO placebo capsule compounded to match PO Acetaminophen capsule

DRUG

IV Solution Placebo

This will serve as the placebo for the IV Acetaminophen intervention

Sponsors & Collaborators

  • TriHealth Inc.

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2019-02-14
Completion
2019-04-12
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03468920 on ClinicalTrials.gov